Investing in a Vision: A Meeting of the Minds in Biotech – Founder & VC in Conversation


Free and open to all.

Investing in a Vision: A Meeting of the Minds in Biotech – Founder & VC in Conversation

Join us for an insightful discussion with Sally Dewhurst from Oxford Science Enterprises and Giacomo Gorini from Gorini Labs, as they share their unique perspectives on the booming biotech ecosystem. This engaging session will explore the challenges and triumphs of building a successful biotech venture from the ground up, securing funding, and navigating the complex investment landscape.
This event offers attendees a unique opportunity to understand the founder’s journey from ideation to funding, and the VC’s perspective on identifying promising biotech ventures.

The discussion will also explore the current state and future trends of the biotech industry, providing attendees with strategies for successful fundraising and building strong investor relationships.

Sally Dewhurst, Oxford Science Enterprises (OSE), Principal, Life Sciences, VC
Sally Dewhurst joined Oxford Science Enterprises in February 2021, bringing with her over eight years of experience in oncology research from world-leading academic institutions. She focuses on identifying new opportunities in the life sciences and supports both the creation of new biotech businesses and the management of the existing portfolio.

Before joining Oxford Science Enterprises, Sally honed her oncology expertise through a post-doctoral fellowship at Rockefeller University and a PhD at the Francis Crick Institute, where she made key discoveries about cancer evolution. Her research has been published in leading journals including Nature Genetics and Nature Communications. Furthering her expertise, she also studied corporate finance at NYU and consulted for The Solution Lab.

Giacomo Gorini, VC-Backed Founder & Researcher

Giacomo Gorini has secured funding from Oxford Science Enterprises, the venture capital firm partnered with Oxford University, to pursue the development of innovative antibody technologies. The investment will support proof-of-concept experiments, paving the way for the establishment of a new company. His research is being conducted within the Department of Biochemistry, in laboratory space generously provided by Professor Simon Draper.

Monday 18th of November, 2024
6:00 – 8:00 pm
The Hub, Kellogg College
60-62 Banbury Rd, Park Town
Oxford OX2 6PN
///shares.composers.healthier